Trap!? PFFA’s Percent Preferred: A Levered Yield Warning for Investors
Virtus InfraCap U.S. Preferred Stock ETF (PFFA) shows a 9.6% distribution yield, driven by borrowed funds. This artic...
Investing
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
17,689 articles
Is Ford Meme Stock Now? Wall Street and Retail Clash
Retail investors push Ford into meme-stock territory as Wall Street holds, sparking a heated debate about the automak...
Kevin Warsh Trial to Tighten Policy Without Trump Backlash
As inflation persists, investors consider whether kevin warsh tighten policy through balance-sheet tools can curb pri...
NVDL Lost Percent Early: Daily Reset Bleeds Leveraged ETF
NVDL plunged sharply in early 2025 as daily rebalancing magnified losses, even as NVDA fell less. Analysts warn this ...
S&P Blasts Above 7,500 Iran as Strait Hope Lifts Oil
Futures markets push the S&P 500 above 7,500 as renewed Iran Strait optimism reduces oil pressure. Analysts warn the ...
67-Year-Old Single Retiree with $920K: Can It Last to 95?
As inflation and market volatility shape retirement outcomes, a prudent plan can stretch a $920,000 nest egg. The key...
Spacex’s Trillion Pitch: Elon’s Vision for a Backup Internet Era
SpaceX is pursuing a bold, trillion-dollar plan to become the backbone of global connectivity. As markets watch, inve...
Nasdaq’s Fast-Track Will Reshape Big Tech, S&P Rules
The Nasdaq plans a 15‑session fast-track entry for AI leaders into the Nasdaq 100, while the S&P considers shortening...
Apple Microsoft’s Capex Wars to Shape MGK Income This Year
Apple and Microsoft are locked in a capital spending race that could determine MGK’s quarterly distributions in 2026....
Markets Pricing Rate Hikes Through 2027 as Fed Cuts Fade
Investors are pricing rate hikes through 2027 as the Fed cuts outlook fades, reshaping bond yields and stock valuatio...
The Math That Should Terrify Index Investors: AI Chips
AI megacaps have powered the bulk of S&P 500 gains over the past two years. When AI-related stocks are stripped out, ...
Two Distinct Growth Paths: Johnson & Johnson vs AbbVie
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...